×

Do you want to link to this External Site and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Please specify your location:

×

Do you want to link to this Amgen Site outside the UK and leave Amgen.co.uk?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Please note, this page is intended for UK healthcare professionals. By clicking to enter this page you are confirming that you are a UK healthcare professional.

×

Do you want to link to this Amgen Site and leave Amgen.co.uk?

Please note this site is only intended for UK Healthcare professionals and UK patients that have been prescribed Prolia®

YOU ARE NOW LEAVING THIS WEBSITE.

Transfer of Value Disclosure to HCPs, HCOs and R&D

2017 Onwards 

Research and Development payments made to Healthcare Professionals and Healthcare Organisations are, from 2017 onwards, listed in aggregate form (for the UK) in the ABPI online database at https://www.abpi.org.uk/our-ethics/disclosure-uk/  and (for Ireland) via IPHA at  https://www.transferofvalue.ie/ .